You are here

HEMODİYALİZ HASTALARINDA NÖROLOJİK KOMPLİKASYONLAR

Neurological complications in hemodialysis patients

Journal Name:

Publication Year:

Abstract (2. Language): 
Aim: To highlight the neurovascular complications of hemodialysis and discuss the therapeutic app¬roaches with the relevant literature. Case Report: A 19- year old man on maintenance hemodialy¬sis who admitted to our clinic with intracerebral hematoma is discussed. Conclusion: Neurovascu¬lar complications are being recognised as the major causes of mortality and morbidity in hemodialy¬sis patients. Prevention of neurovascular complications of uremia and accelerated hypertension requires the cooperation of both the neurologists and nephrologists.
Abstract (Original Language): 
Amaç: Hemodiyalize bağlı nörovasküler komplikasyonların ve tedavi yaklaşımlarının literatürler yardı¬mıyla irdelenmesi. Olgu Sunumu: Hemodiyaliz tedavisi alan ve kliniğimize intraserebral hematom nedeniyle yatırılan 19 yaşında erkek hasta tartışıldı. Sonuç: Hemodiyaliz hastalarında nörovasküler komplikasyonlar mortalite ve morbiditenin önde gelen nedenlerindendir. Kontrolsüz hipertansiyon ve üremiye bağlı nörovasküler komplikasyonların önlenmesi için, bu hastaların nöroloji ve nefroloji uzmanlarının ortak takibinde olması gereklidir.
31-34

REFERENCES

References: 

1. Lo DS, Rabbat CG, Clase CM. Thromboembolism and anticoagulant management in hemodialysis patients: A practical guide to clinical manage-ment. Thromb Res 2006;118:385-95.
2. Wiesholzer M, Harm F, Tomasec G, Barbieri G, Putz D, Balcke P. Incidence of stroke among chronic hemodialysis patients with nonrheumatic atrial fibrillation. Am J Nephrol 2001;21:35-9.
3. Yokoyoma S, Hirano H, Uomizo K, Kajiya Y, Tajitsu K, Kusumoto K. High incidence of microbleeds in hemodialysis patients detected by T2*-weighted gradient-echo magnetic resonance imaging. Neurol Med Chir 2005;45:556-60.
4. Warrell RPJ, Hultin MB, Coller BS. Increased factor VIII/ von Willebrand factor antigen and von Willebrand factor activity in renal failure. Am. J Medicine 1979;66:226-8
5. Von Kaulla KN, Von Kaulla E, Wasantapruck S, Marchioro TL, Starzl TE. Blood coagulation in ure-mic patients before and after hemodialysis and transplantation of the kidney. Arch Surg
1966;92:184-91.
6. Vazquez E, Sanchez- Perales C, Borrego F, Garcia-Cortes C, Lozano C, Guzman M, et al. Influence of atrial fibrillation on the morbido-mortality of patients on hemodialysis. Am Heart J, 2000; 140: 886-90
7. Toyoda K, Fujii K, Fujimi S, Stroke in patients on maintenance hemodialysis: a 22-year single-center study. Am J Kidney Dis 2005;45:1058-66.
8. Stefanidis I, Bach R, Mertens PR, Liakopoulos V, Liapi G, Mann H, Heintz P. Influence of hemodial-ysis on the mean blood flow velocity in the middle cerebral artery. Clin Nephrol. 2005;64:129-37.
9. Saad E, Charra B, Raj DS. Hypertension control with daily dialysis. Semin Dial 2004;17:295-8.

Thank you for copying data from http://www.arastirmax.com